联环药业：苯磺酸氨氯地平片获药品注册证书

Core Viewpoint - The company has received approval from the National Medical Products Administration for the registration of Amlodipine Besylate Tablets, which is a commonly used medication for regulating vascular pressure [1] Group 1 - The approved product is Amlodipine Besylate Tablets with specifications of 5mg and 10mg [1] - The approval was granted to the company's subsidiary, Xinxiang Changle Pharmaceutical Co., Ltd. [1] - This medication is significant in the treatment of hypertension and related cardiovascular conditions [1]